DESIGN AND STATISTICAL ISSUES OF THE MODIFICATION OF DIET IN RENAL-DISEASE TRIAL

被引:97
作者
BECK, GJ
BERG, RL
COGGINS, CH
GASSMAN, JJ
HUNSICKER, LG
SCHLUCHTER, MD
WILLIAMS, GW
机构
[1] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
[2] UNIV IOWA,IOWA CITY,IA 52242
来源
CONTROLLED CLINICAL TRIALS | 1991年 / 12卷 / 05期
关键词
RANDOMIZED; CLINICAL TRIAL; DIET; BLOOD PRESSURE; DESIGN; SLOPE; RENAL;
D O I
10.1016/0197-2456(91)90069-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Modification of Diet in Renal Disease Trial is a multicenter randomized clinical trial for men and women aged 18-70 years with chronic renal disease who are not on dialysis and who have not had a kidney transplant. Study participants are randomized in a 2 x 2 factorial design to diets containing different amounts of protein and phosphorus and to two levels of blood pressure control. The prescribed modifications differ depending on the level of a patient's kidney function. The primary outcome variable to compare diet or blood pressure groups is each patient's slope (or the change) in glomerular filtration rate with time. This paper describes the study design with particular emphasis on sample size determination. Special statistical analysis issues that arise with slope as the outcome are also discussed.
引用
收藏
页码:566 / 586
页数:21
相关论文
共 42 条
[1]  
[Anonymous], 1993, HUMAN ADAPTATION ACC, DOI DOI 10.3998/MPUB.9951
[2]  
BERGSTROM J, 1986, CLIN NEPHROL, V25, P1
[3]   COMPUTING FOR INCOMPLETE REPEATED MEASURES [J].
BERK, K .
BIOMETRICS, 1987, 43 (02) :385-398
[4]  
BRAZY PC, 1990, KIDNEY INT, V37, P1115
[5]   FACTORIAL-DESIGNS IN CLINICAL-TRIALS - THE EFFECTS OF NON-COMPLIANCE AND SUBADDITIVITY [J].
BRITTAIN, E ;
WITTES, J .
STATISTICS IN MEDICINE, 1989, 8 (02) :161-171
[6]  
Cochran W.G, 1957, STAT METHODS, V6th ed
[7]  
COX DR, 1972, ROY STAT SOC, V64, P156
[8]  
EFRON B, 1991, J AM STAT ASSOC, V86, P9, DOI 10.2307/2289707
[9]  
Fleiss J. L., 1986, RELIABILITY MEASUREM
[10]   DESIGNS FOR GROUP SEQUENTIAL-TESTS [J].
FLEMING, TR ;
HARRINGTON, DP ;
OBRIEN, PC .
CONTROLLED CLINICAL TRIALS, 1984, 5 (04) :348-361